We are live on ! Find out more
FAM

Fred Alger Management Portfolio holdings

AUM $22.8B
1-Year Est. Return 64.63%
This Fund
S&P 500
This Quarter Est. Return
+18.62%
1 Year Est. Return
+64.63%
3 Year Est. Return
+243.99%
5 Year Est. Return
+318.3%
10 Year Est. Return
+1,899.64%
AUM
$21B
AUM Growth
+$356M
Cap. Flow
-$1.77B
Cap. Flow %
-8.43%
Top 10 Hldgs %
50.08%
Holding
490
New
56
Increased
118
Reduced
220
Closed
84

Top Sells

Rank Stock Value
1
TSM icon
TSMC
TSM
+$359M
2
APP icon
Applovin
APP
+$255M
3
NTRA icon
Natera
NTRA
+$145M
4
ALAB icon
Astera Labs
ALAB
+$135M
5
DHR icon
Danaher
DHR
+$122M

Sector Composition

Rank Sector Weight
1 Technology 37.02%
2 Communication Services 15.92%
3 Consumer Discretionary 13.84%
4 Industrials 12.34%
5 Healthcare 10.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CDXS icon
351
Codexis
CDXS
$159M
$1.43M 0.01%
299,143
+173,227
+138% +$713K
FLEX icon
352
Flex
FLEX
$41B
$1.39M 0.01%
36,319
-2,798
-7% -$104K
DOW icon
353
Dow Inc
DOW
$21.7B
$1.36M 0.01%
33,911
+8,485
+33% +$396K
VRNA
354
DELISTED
Verona Pharma
VRNA
$1.34M 0.01%
+28,945
New +$1.09M
VCYT icon
355
Veracyte
VCYT
$4.77B
$1.34M 0.01%
33,892
+24,321
+254% +$921K
EWCZ
356
DELISTED
European Wax Center
EWCZ
$1.34M 0.01%
200,860
-129
-0.1% -$849
ARGX icon
357
argenx
ARGX
$54.6B
$1.33M 0.01%
+2,156
New +$1.26M
TEM
358
Tempus AI
TEM
$7.97B
$1.32M 0.01%
38,958
-22
-0.1% -$1.09K
KLC
359
KinderCare Learning Companies
KLC
$637M
$1.29M 0.01%
+72,267
New +$1.73M
JANX icon
360
Janux Therapeutics
JANX
$950M
$1.26M 0.01%
+23,501
New +$1.24M
ONTO icon
361
Onto Innovation
ONTO
$12.5B
$1.22M 0.01%
7,334
-6,266
-46% -$1.14M
MDB icon
362
MongoDB
MDB
$26.2B
$1.17M 0.01%
5,026
-10,150
-67% -$2.87M
CELH icon
363
Celsius Holdings
CELH
$7.5B
$1.17M 0.01%
44,260
-54,142
-55% -$1.61M
XPO icon
364
XPO
XPO
$23.4B
$1.02M ﹤0.01%
7,774
-2,799
-26% -$378K
MRK icon
365
Merck
MRK
$321B
$951K ﹤0.01%
9,498
-33,128
-78% -$3.42M
TXG icon
366
10x Genomics
TXG
$6.28B
$940K ﹤0.01%
65,430
-42
-0.1% -$663
OMCL icon
367
Omnicell
OMCL
$1.69B
$895K ﹤0.01%
+20,109
New +$903K
PYCR
368
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
$807K ﹤0.01%
+43,433
New +$725K
HLT icon
369
Hilton Worldwide
HLT
$72.5B
$806K ﹤0.01%
3,263
-36,578
-92% -$8.95M
QQQ icon
370
PUT
Invesco QQQ Trust
QQQ
$450B
$772K ﹤0.01%
340
+174
+105% +$88K
BFLY icon
371
Butterfly Network
BFLY
$2.14B
$769K ﹤0.01%
+246,558
New +$642K
KROS icon
372
Keros Therapeutics
KROS
$202M
$767K ﹤0.01%
48,481
-10,657
-18% -$554K
IRON icon
373
Disc Medicine
IRON
$3.03B
$747K ﹤0.01%
+11,775
New +$681K
VLTO icon
374
Veralto
VLTO
$23.1B
$740K ﹤0.01%
7,258
-34,047
-82% -$3.63M
PRAX icon
375
Praxis Precision Medicines
PRAX
$8.58B
$731K ﹤0.01%
9,496
-927
-9% -$67.1K

Similar funds

Fred Alger Management's Q4 2024 Portfolio in Review

As of Q4 2024, Fred Alger Management held 490 positions worth $21B, up 1.7% from $20.6B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Fred Alger Management withdrew a net $1.77B in Q4 2024, closing 84 positions and reducing 220 holdings. Its most notable exit was TSMC, an estimated $359M position sold in full.

By sector, the portfolio is most concentrated in Technology at 37% of assets, down from 38% a quarter earlier, followed by Communication Services and Consumer Discretionary.

Against the trend, Fred Alger Management opened a new position in Nebius Group N.V. worth $155M.

  • Fred Alger Management's largest Q4 2024 buy was Nebius Group N.V.: 5,588,985 shares worth $155M.
  • Fred Alger Management added most to Tesla in Q4 2024, an estimated $146M increase.
  • Fred Alger Management's biggest Q4 2024 reduction was Applovin, cutting an estimated $255M.
  • Fred Alger Management fully exited TSMC in Q4 2024, selling an estimated $359M.
  • Fred Alger Management's ten largest holdings make up 50% of its $21B portfolio in Q4 2024.
  • Fred Alger Management opened 56 new positions and closed 84 in Q4 2024.
  • Fred Alger Management's portfolio value rose 1.7% quarter-over-quarter to $21B.

Based on Fred Alger Management's 13F filing for Q4 2024, filed 14 Feb 2025.